Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: long-term results of the TAX 324 randomised phase 3 trial

Jochen H. Lorch(Dana-Farber Cancer Institute), Olga Goloubeva(University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center), Robert I. Haddad(Dana-Farber Cancer Institute), Kevin J. Cullen(University of Maryland, Baltimore), Nicholas J. Sarlis(Sanofi (United States)), Roy B. Tishler(Dana-Farber Cancer Institute), Ming Tan(University of Maryland, Baltimore), J. Fasciano(Morgan Stanley (United States)), Daniel Sammartino(Dana-Farber Cancer Institute), Marshall R. Posner(Icahn School of Medicine at Mount Sinai)
The Lancet Oncology
January 12, 2011
Cited by 443

Abstract


Related Papers

No related papers found

Powered by citation graph analysis